results
Last reviewed 01/2018
The relative risk reductions for various end-points were:
- coronary mortality 24% (p<0.001, 8.3% vs. 6.4%)
- overall mortality 22% (p<0.002, 11.0% vs. 14.1%)
- myocardial infarction 29%
- stroke 19%
- coronary revascularisation 20%